Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer

被引：0
|
作者：
Simon Fung
Yahiya Y. Syed
机构：
[1] Springer Nature,
来源：
Targeted Oncology | 2024年 / 19卷 / 1期
关键词：
D O I：
10.1007/s11523-023-01021-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 129
相关论文
共 50 条
  • [1] Durvalumab: A Review in Advanced Biliary Tract Cancer
    Fung, Simon
    Syed, Yahiya Y.
    TARGETED ONCOLOGY, 2023, 18 (06) : 965 - 972
  • [2] Durvalumab: A Review in Advanced Biliary Tract Cancer
    Simon Fung
    Yahiya Y. Syed
    Targeted Oncology, 2023, 18 : 965 - 972
  • [3] Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer (TOPAZ-1)
    Choe, Jung Wan
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 82 (02): : 105 - 106
  • [4] Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
    Oh, Do-Youn
    He, Aiwu Ruth
    Qin, Shukui
    Chen, Li-Tzong
    Okusaka, Takuji
    Vogel, Arndt
    Kim, Jin Won
    Suksombooncharoen, Thatthan
    Lee, Myung Ah
    Kitano, Masayuki
    Burris, Howard
    Bouattour, Mohamed
    Tanasanvimon, Suebpong
    McNamara, Mairead G.
    Zaucha, Renata
    Avallone, Antonio
    Tan, Benjamin
    Cundom, Juan
    Lee, Choong-kun
    Takahashi, Hidenori
    Ikeda, Masafumi
    Chen, Jen-Shi
    Wang, Julie
    Makowsky, Mallory
    Rokutanda, Nana
    Zotkiewicz, Magdalena
    Kurland, John F.
    Cohen, Gordon
    Valle, Juan W.
    FUTURE ONCOLOGY, 2023, 19 (34) : 2277 - 2289
  • [5] Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date
    Storandt, Michael H.
    Jin, Zhaohui
    Mahipal, Amit
    ONCOTARGETS AND THERAPY, 2024, 17 : 383 - 394
  • [6] Economic evaluation for the US of durvalumab plus gemcitabine and cisplatin (DGC) in advanced biliary tract cancer (BTC)
    Aqel, Osama
    Shen, Yunrong
    Alfayoumi, Ibrahim
    Abraham, Ivo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] A phase II study of tremelimumab, durvalumab, and bevacizumab in advanced biliary tract cancers
    Coffman, Kelley Lauren
    Xie, Changqing
    Hrones, Donna M.
    Monge, B. M. Cecilia
    Kleiner, David E.
    Steinberg, Seth M.
    Redd, Bernadette
    Wood, Brad J.
    Kassin, Michael
    Levy, Elliot
    Benmebarek, Mohamed-Reda
    Greten, Tim F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Treatment of advanced biliary tract cancer
    Koeberle, D.
    ONKOLOGIE, 2011, 34 : 25 - 25
  • [9] Toripalimab in advanced biliary tract cancer
    Li, Wei
    Wang, Yueqi
    Yu, Yiyi
    Li, Qian
    Wang, Yan
    Zhang, Chenlu
    Xu, Xiaojing
    Guo, Xi
    Dong, Yu
    Cui, Yuehong
    Hao, Qing
    Huang, Lujia
    Liu, Houbao
    Liu, Tianshu
    INNOVATION, 2022, 3 (04):
  • [10] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
    Rimini, Margherita
    Fornaro, Lorenzo
    Rizzato, Mario Domenico
    Antonuzzo, Lorenzo
    Rossari, Federico
    Satake, Tomoyuki
    Vandeputte, Hanne
    Vivaldi, Caterina
    Pressiani, Tiziana
    Lucchetti, Jessica
    Kim, Jin Won
    Abidoye, Oluseyi
    Rapposelli, Ilario Giovanni
    Tamberi, Stefano
    Finkelmeier, Fabian
    Giordano, Guido
    Nichetti, Federico
    Chon, Hong Jae
    Braconi, Chiara
    Pirrone, Chiara
    Castet, Florian
    Tamburini, Emiliano
    Yoo, Changhoon
    Parisi, Alessandro
    Diana, Anna
    Scartozzi, Mario
    Prager, Gerald W.
    Avallone, Antonio
    Schirripa, Marta
    Kim, Il Hwan
    Perkhofer, Lukas
    Oneda, Ester
    Verrico, Monica
    Adeva, Jorge
    Chan, Stephen L.
    Spinelli, Gian Paolo
    Personeni, Nicola
    Garajova, Ingrid
    Rodriquenz, Maria Grazia
    Leo, Silvana
    Salani, Francesca
    De Rosa, Antonio
    Lavacchi, Daniele
    Foti, Silvia
    Ikeda, Masafumi
    Dekervel, Jeroen
    Niger, Monica
    Balsano, Rita
    Tonini, Giuseppe
    Kang, Minsu
    EUROPEAN JOURNAL OF CANCER, 2024, 208
12345